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Maintaining genome integrity and transmission of intact genomes is critical for cellular, organismal, and
species survival. Cells can detect damaged DNA, activate checkpoints, and either enable DNA repair or
trigger apoptosis to eliminate the damaged cell. Aberrations in these mechanisms lead to somatic mutations
and genetic instability, which are hallmarks of cancer. Considering the long history of host-microbe coevo-
lution, an impact of microbial infection on host genome integrity is not unexpected, and emerging links
between microbial infections and oncogenesis further reinforce this idea. In this review, we compare strate-
gies employed by viruses, bacteria, and parasites to alter, subvert, or otherwise manipulate host DNA dam-
age and repair pathways. We highlight how microbes contribute to tumorigenesis by directly inducing DNA
damage, inactivating checkpoint controls, or manipulating repair processes. We also discuss indirect effects
resulting from inflammatory responses, changes in cellular metabolism, nuclear architecture, and epigenome
integrity, and the associated evolutionary tradeoffs.Introduction
Microbial infections mount hostile attacks on host signaling
pathways and cellular integrity. Perhaps nothing is as chal-
lenging to host cells as pathogen attacks on the host genome
and processes that protect genome integrity. It is inevitable
that in some contexts pathogen-induced genomic damage
contributes to tumorigenesis, and as such, 20% of all human
cancers are causally related to pathogenic agents (de Martel
et al., 2012; Zur Hausen, 2009). Pathogens employ a plethora
of strategies to harness or inactivate the DNA damage response
(DDR), a host mechanism that protects genome integrity, and
circumvent barriers imposed by DNA damage checkpoints
(reviewed by Guerra et al., 2011; Turnell and Grand, 2012; Weitz-
man et al., 2010).
In this review, we compare the strategies employed by viruses,
bacteria, and parasites to affect the host’s DNA damage and
repair pathways. We highlight specific direct and indirect mech-
anisms involved as well as the genotoxic outcomes of these
host-pathogen interactions (see Figure 1). The evolutionary
tradeoffs resulting from the impact of host-microbe interactions
on genome integrity are also discussed. Studies of viruses,
bacteria, and parasites highlight the importance of host cellular
pathways that maintain genome and epigenome integrity and
provide insights into therapeutic approaches to pathogen-
induced tumorigenesis.
Genome Integrity and Tumorigenesis
While it is generally accepted that most cancers are genetically
unstable, the origins of this instability and the molecular mecha-
nisms responsible for inducing tumorigenic mutations and
rearrangements are numerous and unclear in several cases.The resolution and scale of genetic instability varies consider-
ably, from subtle sequence changes involving base substitu-
tions, deletions, or insertions of a few nucleotides to aneuploidy
and gross alterations in chromosome structure (Lengauer et al.,
1998). Picking apart the role of specific initiators and drivers crit-
ical for tumor initiation remains a nontrivial challenge. Microbial
infection can influence cellular functions that represent classical
hallmarks of cancer, including stimulating proliferative growth,
evading growth suppression, and preventing apoptosis, as well
as emerging hallmarks, such as altered cellular energetics and
avoidance of immune destruction (Hanahan and Weinberg,
2011; see also review by Mesri et al., 2014 in this issue). Infec-
tious agents can act as direct carcinogens or can indirectly
contribute to tumorigenesis through induction of chronic inflam-
mation, leading to either localized mutational changes and/or
global chromosomal defects, which are features of the cancer
genomic landscape.
DNA Damage and Repair
Repair pathways recognize and restore a range of DNA anoma-
lies, including mismatches, abnormal bases, stalled replication
forks, single-stranded DNA nicks, and double-stranded DNA
breaks (DSBs) (Friedberg et al., 2006) (see Figure 2). The
mismatch repair (MMR), base excision repair (BER), and nucleo-
tide excision repair (NER) pathways respond to specific lesions
in DNA residues. DSBs present a particularly dangerous lesion
and are repaired by two principal pathways: the error-prone
nonhomologous end-joining (NHEJ) pathway functions in all
phases of the cell cycle, while the high-fidelity homologous
recombination (HR) pathway requires a template for repair and
utilizes available sister chromatids during the S and G2 phasesCell Host & Microbe 15, March 12, 2014 ª2014 Elsevier Inc. 283
Figure 1. Interactions between Microbial Pathogens and Pathways
that Maintain Host Genome Integrity
The schematic illustrates how infectious agents (viruses, prokaryotic bacteria,
or eukaryotic parasites) associated with tumorigenesis converge on common
strategies that challenge DNA integrity and genome stability. These include
direct effects of pathogen-encoded genotoxins and oncoproteins as well as
indirect outcomes of microbial infection and inflammatory responses. Please
see the main text for detailed explanations of the host pathways that are
impacted by the direct and indirect activities of microbial pathogens.
Figure 2. Common DNA Damage Intermediates and Repair
Pathways
Although much of this review is focused on double-strand break repair path-
ways, many of these other repair processes can be impacted by microbial
infections.
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recognize the damage and activate signaling cascades to recruit
mediators for repair and induction of proliferation checkpoints
(reviewed by Ciccia and Elledge, 2010). DNA damage activates
protein kinases, including the ataxia telangiectasia mutated
protein kinase (ATM), the ATM and Rad3-related kinase (ATR),
the DNA-dependent protein kinase (DNA-PK), and the down-
stream checkpoint effector kinases Chk1 and Chk2 (Ciccia and
Elledge, 2010) (see Figure 3). In addition to phosphorylation,
other posttranslational modifications (PTMs) are critical for the
cellular DNA damage and repair machinery (reviewed by Polo
and Jackson, 2011). Covalent, but reversible, modification by
ubiquitin and SUMO recently emerged as crucial components
of the cellular DDR (Jackson and Durocher, 2013). The DDR
network is established through recognition of these PTMs by
high-affinity binding modules, such as BRCT and FHA domains
that bind phosphorylated epitopes (reviewed by Reinhardt and
Yaffe, 2013), Tudor domains that bind methylated sites, ubiq-
uitin-binding domains (UBDs), and SUMO-interacting motifs
(SIMs) (Polo and Jackson, 2011). PTMs affect localization, pro-
tein-protein interactions, and protein activity to regulate damage
recognition and repair processes.
Temporal regulation of damage recognition and repair is
crucial to maintain genome integrity, and PTMs serve to recruit
repair factors to damage sites. The ATM kinase is activated by
DSBs, whereas ATR responds to single-strand DNA (ssDNA)
resulting from resected DNA at breaks or stalled replication forks
(Mare´chal and Zou, 2013). Each DNA damage lesion has a
specific damage sensor. Specifically, the Mre11/Rad50/Nbs1
(MRN) complex senses DSBs, whereas ATR is recruited to
ssDNA bound by RPA through its cofactor ATRIP and is acti-
vated by binding proteins such as TOPBP1 (see Figure 3). Phos-
phorylation of the histone variant H2AX at DSB sites forms
gH2AX, a marker of breaks. Phosphorylated gH2AX is bound284 Cell Host & Microbe 15, March 12, 2014 ª2014 Elsevier Inc.by the mediator of checkpoints, MDC1, which is itself phosphor-
ylated and then recognized by the FHA domain of the E3 ligase
RNF8. Protein ubiquitination at DSBs signals the recruitment of
RNF168, an E3 ligase with ubiquitin-binding domains. RNF8/
RNF168-dependent ubiquitination promotes recruitment and
retention of repair factors, and deubiquitinating proteins dynam-
ically regulate ubiquitin chains at damage sites. Numerous DNA
repair factors are SUMOylated in the DDR, and recognition by
SIM binding promotes interactions at repair sites or can lead to
turnover by SUMO-targeted ubiquitin ligases (Polo and Jackson,
2011). Acetylation also plays an important role in DSB repair, and
the acetylase Tip60 is recruited to modify histones and DDR
proteins (Price and D’Andrea, 2013). All these critical orches-
trating events for the DDR can be perturbed by microbial infec-
tions, with detrimental consequences for host genomic integrity.
Pathogen Contributions to Tumorigenesis
It is recognized that infection is a major contributor to cancer,
with certain infectious agents classified as direct human carcin-
ogens (de Martel et al., 2012). Some pathogens encode proteins
required to maintain their own genetic integrity (e.g., bacteria),
whereas others rely extensively on the host machinery (e.g.,
viruses). Pathogens impact host cell genomes directly through
genotoxins and oncoproteins that induce changes to cellular
DNA and by impairing DNA repair mechanisms (see Figure 1).
Genomic integrity is also impacted indirectly as a result of path-
ogen replication and induced inflammation. Microbial pathogens
manipulate cellular environments to create conditions conducive
to their own replication; they alter cellular structures, divert
signaling pathways, modify host epigenetic programs, and influ-
ence metabolism. The host DDR cascades activated by patho-
gens serve to combat infection and can therefore be viewed
as a branch of cellular defense. These are counteracted by
numerous microbial strategies, with devastating consequences
for host cells and the infected organism. Mining host and path-
ogen genomes provides insights into the intricate mechanisms
that contribute to this dynamic interface and coevolution of de-
fense and counterattack strategies in tumorigenesis.
Figure 3. The Network of DDR Signaling Pathways
Sensors recognize structures at sites of DNA damage induced by DNA breaks
and replication stress. Signal is transmitted by transducer kinases, and
mediator proteins are recruited to amplify the signal through ubiquitin modi-
fications and checkpoint kinases. The effectors of the pathway mediate
cellular processes required for the maintenance of genome integrity.
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Viruses are the major infectious contributors to cancers. The
history of tumor virology and in-depth analysis of viral oncopro-
teins has been covered in previous reviews (Howley and Living-
ston, 2009; Moore and Chang, 2010; Zur Hausen, 2009). A
number of viruses are associated with human cancer: (1)
Epstein-Barr virus (EBV) is associated with Burkitt lymphoma
and Hodgkin’s lymphoma and is detected in nasopharyngeal
carcinoma; (2) hepatitis B virus (HBV) and hepatitis C virus
(HCV) are major etiological factors for hepatocellular carcinoma
and have been associated with non-Hodgkin lymphoma; (3)
human T-lymphotrophic virus 1 (HTLV-1) is involved in adult
T cell leukemia; (4) high-risk human papillomaviruses (HPVs)
cause cervical carcinomas and are prevalent in other anogenital
cancers and head and neck cancers; (5) Kaposi’s sarcoma-
associated herpesvirus (KSHV) is the causative agent of
Kaposi’s sarcoma, primary effusion lymphoma, and multicentric
Castleman’s disease; and (6) Merkel cell polyomavirus (MCV) is
implicated with Merkel cell carcinoma. These are considered
directly carcinogenic in humans (except for MCV) but are unlikely
to be the only viral agents that contribute toward tumorigenesis.
The oncogenic potential of these viruses is unleashed over long
periods, due to accumulated mutations and genome instability.
Some virus genomes can persist in tumors in a latent state,
where there is no active virus replication or virion production.
For some tumor viruses, the viral genome becomes integrated
into the host genome (e.g., HBV, HTLV-1, HPV, and MCV),
whereas the herpesvirus genomes (EBV and KSHV) are typically
maintained as latent episomal genomes. Viral proteins act as
direct oncogenes required to maintain the transformed pheno-
type as well as indirect effectors that promote cancer through
infection and inflammation. Recent genomic sequencing ap-proaches to cancer have identified viruses associated with
human tumors (Feng et al., 2008), located integration sites, and
defined viral impacts on cellular gene expression profiles (Tang
et al., 2013). Some viruses that are not directly implicated as
causative agents in human cancer also target common molecu-
lar pathways relevant to transformation, and transient inactiva-
tion of essential tumor suppressors could theoretically facilitate
the accumulation of transforming genetic lesions (Niller et al.,
2011). Viral infection can cause transformation of nonpermissive
cell types and induce tumors in experimental animal models. The
links between viruses and DNA damage pathways in cancer
highlighted how viruses contribute to the complex multistep
process of transformation (McFadden and Luftig, 2013; Turnell
and Grand, 2012; Wallace and Galloway, 2014). In addition to
the direct effects of transforming viral oncoproteins, infection
can also indirectly affect tumor suppression and alter epigenetic
regulators of cellular function. Oncogene expression (both viral
and cellular) induces replicative stress and DDR activation,
which lead to activation of cell-cycle checkpoints, p53-mediated
apoptosis, and senescence; these barriers must be overcome
for tumorigenesis (McFadden and Luftig, 2013).
Bacteria
The best-characterized example of bacterial contribution to
cancer is Heliobacter pylori infection, which is well established
as a major risk factor for gastritis leading to gastric cancer
(reviewed by Touati, 2010; see review by Hatakeyama, 2014 in
this issue). Other bacterial infections have not been classified
as direct human carcinogens but may result in genomic alter-
ations and transformation associated with human cancer
(Touati, 2010; Vogelmann and Amieva, 2007). Infections can be
mutagenic as a direct result of cytotoxins or can causemutations
indirectly as a consequence of chronic inflammation. Further-
more, recent studies in germfree mice have demonstrated the
tumor-promoting effects of the microbiota on cancer progres-
sion in a range of organs, suggesting that antibiotics can reduce
tumor burden in human patients. Changes in the complex com-
munity of microbes that inhabit the gastrointestinal tract (the gut
microbiome) have been shown to contribute to tumorigenesis in
inflammation-driven colon cancer (Zackular et al., 2013; see also
review by Sears andGarrett, 2014 in this issue). Another example
is gallbladder cancer, which is associated with chronic Salmo-
nella typhi infections (Samaras et al., 2010). Mucosa-associated
lymphoid tissue (MALT) lymphomas can be caused by uncon-
trolled adaptive immune responses upon chronic bacterial infec-
tions, including H. pylori and Campylobacter jejuni (Guidoboni
et al., 2006). Bacterial infections may contribute to cancer pro-
gression in a number of complex ways, such as challenges to
the integrity of epithelium and the intestinal barrier, effects on
host-microbiota interactions and bacterial communities, and
chronic inflammation.
Parasites
The association between parasite infection and cancer is less
clear, although there is some emerging clinical and epidemiolog-
ical evidence. The flagellate Trichomonas vaginalis has been
linked to cervical and prostate cancer (Sutcliffe, 2010). Malaria
was linked to development of endemic Burkitt lymphoma (eBL)
by Denis Burkitt in Sub-Saharan Africa in the 1960’s, andmalaria
antibodies have been detected in cancer patients. The onco-
genic herpes virus EBV contributes to the pathogenesis ofCell Host & Microbe 15, March 12, 2014 ª2014 Elsevier Inc. 285
Figure 4. Viruses and Viral Products that
Target the DNA Damage and Repair
Pathways
Viral infection and viral gene products (shown
outside the gray boxes) activate DDR signaling
(shown within the gray boxes) directly or indirectly
through induction of ROS and replication stress.
Viral oncoproteins activate and are acted upon by
damage kinases, as indicated by two-way arrows.
Viruses act at every stage of the DDR pathway
to disrupt signaling checkpoints and repair pro-
cesses, as shown. Many of these have been
shown to contribute to the process of cellular
transformation (see the main text for details and
references).
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immune system in young children by expanding the B cell pool
and reactivating latent EBV (Bouvard et al., 2012). The related
apicomplexan Toxoplasma gondii has been associated with
some adenomas and lymphomas (Zhang et al., 2002). The clear-
est direct links between parasites and tumorigenesis are the
apicomplexan parasites Theileria annulata, Theileria parva, and
Cryptosporidium parvum. C. parvum infection causes diarrhea
and has been implicated in gastrointestinal carcinoma in an
experimental mouse model (Certad et al., 2010). Although the
mechanism is unknown, recent studies demonstrated gastroin-
testinal neoplasia and adenoma formation in the gut in immuno-
compromised mice infected with C. parvum (Benamrouz et al.,
2012). Theileria spp. infect leukocytes in bovine hosts and induce
a transformed lymphoproliferative disease with features of can-
cer. Many studies have described host cell signaling pathways
that contribute to Theileria-induced transformation, including
activation of host c-Jun and Myc oncogenes (Chaussepied
and Langsley, 1996; Shiels et al., 2006), and the importance of
these pathways has been demonstrated in immunocompro-
mised mouse models (Lizundia et al., 2006).
Pathogen Oncoproteins and Genotoxins and
Their Intersection with DDR Mechanisms
Manipulation of DDR Signaling by Viral Infections
Viruses activate DDR signaling pathways, as well as systemati-
cally dismantle aspects of the DDR network, through multiple
strategies (reviewed by Turnell and Grand, 2012) (Figure 4). Virus
infection activates DDR signaling through both ATM and ATR
kinases. The extent to which damage-signaling cascades
activated by viruses overlap with those observed in response
to DSBs or replication stress, or whether there are unique
pathogen-directed substrates, remains to be determined. One286 Cell Host & Microbe 15, March 12, 2014 ª2014 Elsevier Inc.feature that distinguishes viruses from
other microbial infections is that their
genetic material is directly released into
the infected cell, resulting in a conflict
with the cellular genome, especially for
DNA viruses that replicate in the nucleus
(Weitzman et al., 2010). These foreign
genomes could be recognized as DNA
damage, although in most viral systems
it has not been conclusively determined
whether the viral genome itself is suffi-cient to trigger the cellular responses. Viral replication intermedi-
ates can activate the DDR, and viral replication proteins can also
directly induce damage to host genomes. In the case of HPV,
replication initiated from integrated HPV origins induces a
damage response that may promote genome instability (Kadaja
et al., 2009), and the HPV-E1 replication protein alone activates
the DDR (Fradet-Turcotte et al., 2011; Sakakibara et al., 2011).
The DDR can also be activated by virus infection as a result of
the aberrant entry into S phase, by replicative stress, directly
by viral oncoproteins, and indirectly through reactive oxygen
species (ROS) production. Viruses often overcome the inhibitory
effects of DDR and the checkpoints that they have activated.
This is seen for HPV, where the E6 and E7 oncoproteins that
are the primary viral factors responsible for initiation and pro-
gression of cervical cancer contribute to many functions that
combine to subvert cell-cycle checkpoints, induce genomic
instability, and inhibit apoptosis (reviewed by Moody and Lai-
mins, 2010; Wallace and Galloway, 2014).
Human herpesviruses activate aspects of cellular damage
signaling that can promote efficient lytic replication (Lilley
et al., 2005; Wilkinson and Weller, 2004). Herpesviruses are
also characterized by their ability to establish latency, where viral
gene expression from episomal genomes is silenced by cellular
chromatinization. Viral oncoproteins expressed by the latency
program of some transforming herpesviruses can also induce a
DDR. For example, EBV infection of B cells in culture induces
transient activation of ATM signaling as a result of cellular hyper-
proliferation driven by early latent oncoproteins (Nikitin et al.,
2010). The related KSHV also elicits oncogene-induced senes-
cence via a virus-encoded cyclin (Koopal et al., 2007). Growth
suppressive consequences of DDR activation by viruses can
be limiting for viruses. During latent infection by herpesviruses,
outgrowth of immortalized cells is only achieved in rare
Figure 5. Bacterial Infections and Secreted
Products Impact Many Aspects of the
Eukaryotic Damage Response
Damage is induced by bacterial cell adhesion,
genotoxins, and production of ROS. There is also
a limited impact on downstream signaling, which
affects recruitment of damage factors and,
potentially, repair processes (see the main text for
details and references).
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sures by virus-encoded latent proteins (Leidal et al., 2012b;
Nikitin and Luftig, 2012). For KSHV, it is observed that viral onco-
gene expression during early stages of infection activates ATM
signaling, but the DDR is downregulated in advanced Kaposi’s
sarcoma tumors (Koopal et al., 2007). Oncogene-induced
senescence is overcome by EBV proteins EBNA3C (Nikitin
et al., 2010) and LMP1 (Yang et al., 2000) and by KSHV protein
v-FLIP (Leidal et al., 2012a). The efficiency of B cell immortali-
zation by EBV infection can be enhanced by inhibition of the
ATM and Chk2 kinases (Nikitin et al., 2010).
Viruses manipulate the DDR network at multiple points, block-
ing signaling and checkpoints at the step of DNA damage
sensors, the damage kinases, the checkpoint kinases, and the
effector molecules (Figure 4). Early adenovirus (Ad) proteins
prevent activation of ATM and ATR by degrading and mislocaliz-
ing the MRN complex (Carson et al., 2003; 2009). Downstream
checkpoint kinases are targeted by the HTLV-Tax oncoprotein
that binds and inactivates both Chk1 and Chk2 (Boxus et al.,
2008) and by the EBV-EBNA3C protein that inactivates the
Chk2 effector kinase (Choudhuri et al., 2007). During herpes sim-
plex virus (HSV) infection, recruitment of repair factor to sites of
incoming virus genomes is blocked by degradation of RNF8 and
RNF168 by the viral ICP0 ubiquitin ligase (Lilley et al., 2011; Lilley
et al., 2010). Viral targeting of the DNA-PKwill have a direct effect
on the ability of the cell to repair breaks through NHEJ. DNA-PK
is targeted by Ad-E4 proteins (Boyer et al., 1999) and the Tax on-
coprotein of HTLV-1 (Durkin et al., 2008; Ramadan et al., 2008).
Ad oncoproteins prevent both DDR signaling and processing of
the virus genome by degrading the MRN complex (Carson et al.,
2003; Stracker et al., 2002), as well as other repair factors such
as TOPBP1, and DNA ligase IV (Turnell and Grand, 2012).
Manipulation of DDR Signaling by Bacterial Infections
Several pathogenic bacterial strains have been demonstrated to
induce DSBs and the DDR (Figure 5).H. pylori infection of humanCell Host & Microbe 1gastric epithelial cells induces DNA
damage accompanied by ATM and ATR
signaling to gH2AX, Chk1, and Chk2,
checkpoint activation, and apoptosis
(Jang et al., 2012; Toller et al., 2011).
Recently, Chlamydia infections were
also reported to induce DSB hallmarks,
including gH2AX (Chumduri et al., 2013).
In addition to activating aspects of the
DDR, bacteria can also block further
downstream steps, as seen with Chla-
mydia. DSBs induced by Chlamydia tra-
chomatis infection fail to recruit repair
proteins such as 53BP1, and the Chk1/Chk2 kinases are not activated (Chumduri et al., 2013). Bacterial
infections can also impact repair pathways: H. pylori infection
leads to inhibition of nucleotide repair by downregulation at
both the gene and protein level of factors involved in MMR and
BER (Machado et al., 2010).
The effects of chronic inflammation may also be augmented
by bacterial toxins that directly induce DNA damage (reviewed
by Guerra et al., 2011). Cytolethal distending toxins (CDTs) are
genotoxins produced by many clinically important bacterial
pathogens (Jinadasa et al., 2011) that can induce cell-cycle
arrest and apoptosis in a broad range of mammalian cell lines
(Guerra et al., 2011). The active subunit of CDT is a phosphodi-
esterase that can initiate DSBs and a DDR similar to that elicited
by ionizing radiation (Alaoui-El-Azher et al., 2010). This was
demonstrated for CDT from Aggregatibacter actinomycetemco-
mitans (Alaoui-El-Azher et al., 2010), Haemophilus ducreyi (Fri-
san et al., 2003), and Escherichia coli (Fedor et al., 2013). The
active subunit CdtB translocates to the host nucleus, and its
DNase activity may contribute to DNA damage and carcino-
genic potential (Elwell and Dreyfus, 2000; Nesic et al., 2004).
DSBs in human cells transiently infected with commensal and
extraintestinal pathogenic E. coli may be due to colibactin,
another toxin encoded by a widely distributed genomic island
that activates the ATM-Chk2 signaling pathway and the G2/M
checkpoint (Nougayre`de et al., 2006). CDT and colibactin can
be considered bacterial genotoxins that directly induce DNA
damage and genomic instability (Cuevas-Ramos et al., 2010;
Nesic et al., 2004). Chronic exposure to sublethal doses of
CDT increases mutations, chromosomal aberrations, and
anchorage-independent growth while decreasing DDR acti-
vation (Guidi et al., 2013). The H. hepaticus CDT promotes
dysplasia in a mouse model of hepatocarcinogenesis (Ge
et al., 2007), and E. coli colibactin was functionally linked to
colorectal cancer development in mice (Arthur et al., 2012).
Most of these effects have been reported using high doses of5, March 12, 2014 ª2014 Elsevier Inc. 287
Figure 6. Parasite Infection and Effect on
DDR Pathways
In contrast to viral and bacterial infections, the
mechanistic links between infection by intracel-
lular parasites and DDR signaling pathways
remain poorly defined. There are a few examples
of parasite-encoded proteins, which are secreted
into the host cell and directly target signaling
pathways. It is also likely that parasite modulation
of mitochondria and ROS levels affects host cell
signaling indirectly (see the main text for details
and references). The contrast between the details
in this figure and those of viral infection highlight
future avenues of research.
Cell Host & Microbe
ReviewCDT, but recent experiments with lower doses of E. coli CDT
suggested that damage signaling is caused by induction of
ssDNA nicks that are subsequently converted to DSBs during
S phase (Fedor et al., 2013). DNA breaks and recruitment of
repair factors have also been reported for H. pylori in a manner
that depends upon direct pathogen contact with human cells
but is independent of known virulence factors (Toller et al.,
2011). Together, these observations suggest molecular mecha-
nisms for the observed genetic alterations detected in bacterial-
induced carcinogenesis.
Manipulation of DDR Signaling by Parasitic Infections
In general, knowledge of the direct mechanisms by which
parasites contribute to cancer and manipulate the DDR
lags behind studies of viruses and bacteria (Figure 6). There
is evidence that apicomplexan parasites directly target the
p53 pathway; for example, Theileria annulata infection was
linked to cytoplasmic sequestration of p53 and physical asso-
ciation with parasite membranes (Haller et al., 2010). T. parva-
infected lymphocytes have increased levels of MDM2, with
alternatively spliced isoforms and impaired DNA damage
responses (Hayashida et al., 2013). Parasite-encoded proteins
responsible for manipulating host pathways have remained
relatively elusive. A recent report identified a key dense granule
protein, GRA16, that is exported by Toxoplasma and targets
host nuclear proteins such as deubiquitinase HAUSP and
PP2A phosphatase (Bougdour et al., 2013). This results in de-
regulation of the p53 checkpoint pathway and is critical for
parasite pathogenesis. Theileria infection induces expression
of the miR-155 oncomiR, which targets DET1, a component of
the ubiquitin ligase complex containing DNA damage-binding
protein 1 (DDB1) (Marsolier et al., 2013). These recent studies
provide evidence for links between parasite-encoded proteins
and host signaling pathways that regulate apoptosis and dam-
age signaling. Although these events were linked to parasite
survival, they have not been formally linked to DDR signaling,
and we can therefore only speculate about their direct contribu-288 Cell Host & Microbe 15, March 12, 2014 ª2014 Elsevier Inc.tion to host cell phenotypes, genome
integrity, and eventual tumorigenesis.
Indirect Effects of Microbial
Infections on Genome Integrity
In addition to the direct effects of specific
pathogen-encoded proteins on the
DDR as discussed above, there are
numerous examples of indirect effectson host genome integrity resulting from pathogen infection and
the associated inflammatory responses.
Reactive Oxygen Species
An obvious indirect effect of pathogen infection is the production
of ROS. Virus infection and viral oncoproteins can induce ROS
that cause DNA damage and DDR activation. ROS-dependent
damage signaling is induced by HTLV-Tax (Kinjo et al., 2010)
and EBV-EBNA1 (Gruhne et al., 2009). Persistent infection of
human cells with the bacterial pathogen Chlamydia trachomatis
induces gH2AX, possibly due to increased ROS (Chumduri et al.,
2013). ROS production also underlies the transformed pheno-
type associated with intracellular Theilieria parasites and drives
the metabolic reprogramming of host cells (Medjkane et al.,
2013). The widespread effects of microbe infection on inflamma-
tion and ROS production inevitably contribute to pathogen-
induced tumorigenesis but fall beyond the scope of this review.
Spatial Reorganization of Cellular Structures
Since dynamic subnuclear structures facilitate cellular re-
sponses to DNA damage, disruption of nuclear architecture by
microbes can impact cellular function. Viral infections often
disrupt nuclear substructures by targeting specific cellular
proteins, and pathogens create new protein complexes to
promote replication. Cellular proteins involved in DNA replication
and repair accumulate at virus-induced structures and are
exploited to aid virus replication (reviewed by Schmid et al.,
2014). The small circular genomes of polyomaviruses replicate
at centers where large T antigen colocalizes with the MRN
complex and ATM (Li et al., 2013a; Zhao et al., 2008). ATM
activation byHPV is also accompanied by accumulation of repair
factors at replication centers and viral genome amplification
in differentiated cells appears dependent on damage signaling
(Moody and Laimins, 2009). In some cases, there appears to
be selective recruitment of DNA repair proteins to virus replica-
tion centers. ATR and its cofactors ATRIP and RPA accumulate
at replication centers during Ad infection, although ATR signaling
is prevented by strategies that vary between different Ad
Cell Host & Microbe
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proteins can also be substrates of DNA damage kinases, such
as ATM-mediated phosphorylation of the simian virus type 40
(SV40) large T antigen (Shi et al., 2005), which promotes virus
replication (Zhao et al., 2008).
Viral genomes released from virus particles in the nucleus can
be recognized by cellular proteins that assemble structures at
sites associated with the incoming viral genomes. These include
DNA repair proteins as well as components of PML nuclear
bodies (Everett et al., 2006; Lilley et al., 2011). Other cellular
sensors of foreign DNAmay also play a role in recognition of viral
genomes. In particular, IFI16 is a protein implicated in DNA
damage complexes (Ouchi and Ouchi, 2008) that may also act
as a nuclear sensor of herpesvirus genomes (Kerur et al., 2011;
Li et al., 2013b). The MRN DNA repair complex is inactivated
by some Ad oncoproteins, and in the absence of these proteins
the MRN complex accumulates at sites of viral DNA replication
(Stracker et al., 2002). There appears to be a connection
between the sensors of DNA damage that respond to virus
genomes and DNA sensors that mediate innate immune re-
sponses. Both IFI16 and Mre11 have been implicated in sensing
foreign DNA in the nucleus and cytoplasm and play roles in
induction of antiviral cytokines (Kondo et al., 2013; Li et al.,
2013b). Targeting of these DNA sensors by virus proteins to
counteract innate immune processes may therefore also impact
their role in DNA repair responses and thus indirectly influence
the host’s genome integrity. Viral proteins can also form struc-
tures that sequester or inactivate cellular repair proteins. Ad-
E1b55K and Ad-E4orf3 oncoproteins accumulate in cytoplasmic
aggresomes that sequester both p53 and the MRN complex
proteins (Araujo et al., 2005; Liu et al., 2005). The Ad-E4orf3
oncoprotein also polymerizes to form nuclear structures that
immobilize the MRN complex and prevent recruitment to DNA
damage sites (Carson et al., 2009; Ou et al., 2012). The HTLV-
Tax protein is another example of a viral oncoprotein that
sequesters MDC1 in pseudo DNA damage sites that compete
with the regular cellular DDR (Belgnaoui et al., 2010).
Epigenetic Reprogramming upon Infection
Since DNA damage and DNA repair are influenced by nucleo-
some structure and chromatin architecture (Price and D’Andrea,
2013), pathogen influences on host epigenomes can indirectly
affect host genome integrity. Histones are subject to a plethora
of complex and dynamic PTMs, including phosphorylation, acet-
ylation, methylation, and ubiquitination, that define the degree of
DNA accessibility and facilitate protein recruitment. The histone
variant H2AX, a key player in the response to DSBs, can undergo
multiple PTMs, including phosphorylation that generates gH2AX,
acetylation by Tip60, and ubiquitination by RNF8/RNF168 (Price
andD’Andrea, 2013). Viruses, bacteria, and parasites all provoke
pathways that result in histone modifications and chromatin
remodeling of infected cells, providing tactics to manipulate
the DDR.
Virus
Phosphorylated H2AX (gH2AX) is observed during infection by
many viruses. Staining for gH2AX is detected at replication cen-
ters or sites of the large T antigen for the polyomaviruses SV40
(Zhao et al., 2008) and MCV (Li et al., 2013a). Activated ATM in-
duces gH2AX during HPV infection (Moody and Laimins, 2009)
and may recruit other DNA repair factors that accumulate at viralcenters and at foci induced by expression of replication proteins
E1 and E2 (Gillespie et al., 2012; Sakakibara et al., 2011). In addi-
tion to cellular kinases, there are herpesvirus kinases that directly
phosphorylate H2AX to promote infection (Tarakanova et al.,
2007). These herpesvirus kinases are conserved across the
family and can also phosphorylate other DNA repair proteins
includingTip60 (Li et al., 2011). SincegH2AXaccumulates at sites
associatedwith incomingHSV viral genomes and facilitates virus
replication (Lilley et al., 2011), it could alsoplay a role in protecting
ends of viral genomes or facilitating circularization of viral DNA. In
the case of KSHV, infection induces gH2AX (Koopal et al., 2007),
and its interaction with the latency-associated nuclear antigen
(LANA) may increase binding to viral terminal repeats and pro-
mote episome persistence (Jha et al., 2013). It will be important
to establish the extent to which gH2AX and other damage-asso-
ciated histone modifications detected during virus infection
occur on viral versus cellular DNA. Viruses may also encode
factors that protect viral genomes from recognition by cellular
histones and DNA repair sensors. The histone-like protein VII of
Ad has been suggested to protect incoming virus genomes
from recognition and checkpoint activation (Karen and Hearing,
2011), and it is possible that subsequent release of this protein
from viral DNA allows it to become part of cellular chromatin.
Alterations to chromatin marks induced by pathogens may
have multiple outcomes, regulating DNA repair responses in
addition to gene expression and antiviral defenses. The E1A
oncoprotein of Ad prevents monoubiquitination of H2B as a
way to block interferon induction (Fonseca et al., 2012). Monou-
biquitination ofH2B is observed uponDNAdamage and is impor-
tant for repair, implying that viral evasion of innate immunity may
also impact DNA repair. Degradation of RNF8/RNF168 ligases by
HSV-ICP0 protein results in decreased ubiquitinated H2A that
prevents recruitment of downstream cellular repair factors but
may also overcome transcriptional silencing (Lilley et al., 2010;
2011). Someviral oncoproteins directly impact epigenetic control
of the host genome. The HBV-X protein (HBX) induces aberrant
epigenetic modifications at multiple levels, including hyperme-
thylation of genomic DNA due to increases in DNA methyltrans-
ferases, hypomethylation within promoters of tumor-promoting
genes, and altered histone modifications (Tian et al., 2013).
Bacteria and Parasites
Our understanding of pathogen-associated alterations of his-
tone modifications is still rudimentary, and we do not yet have
a sense of the global effects of infection on histone function.
Many bacteria and parasites produce secreted factors that enter
infected cell nuclei and interfere with chromatin regulation (re-
viewed by Bierne et al., 2012), but other than the gH2AX mark
discussed earlier, the impact of these chromatin regulators on
the DDR is unclear. Cellular transformation induced by the para-
site Theileria is accompanied by modulation of host histone-
modifying enzymes, such as the H3K4 methyltransferase
SMYD3, which contributes to the transformed and metastatic
phenotypes (Cock-Rada et al., 2012). Secreted bacterial pro-
teins can directly modify the host chromatin landscape and pro-
mote efficient intracellular replication by repressing host gene
expression (Rolando et al., 2013), that could also impact DNA
damage responses. It is intriguing to speculate that microbial
infections that affect host epigenetic machineries might leave a
mark that would influence subsequent infections and tumorCell Host & Microbe 15, March 12, 2014 ª2014 Elsevier Inc. 289
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epigenetic modifications affect DNA damage and repair path-
ways and the extent to which histone PTMs contribute to tumor-
igenesis associated with bacterial or parasite infections.
Indirect Effects of Evolutionary Tradeoffs
Pathogen and host coevolution in the context of mutual conflict
shapes both genomes. Signs of positive selection are character-
istic evolutionary signatures of these genetic conflicts. In fact,
DNA repair proteins show signs of positive selection (Demogines
et al., 2010). Positive selection in genes with fundamental cellular
functions, such as DNA repair, can result in alleles that are not
fully optimized for their cellular functions due to the pressure to
avoid inactivation by pathogenic attacks. Thus, the evolution of
host genes that enables them to counteract microbial proteins
interacting with repair pathways may make them vulnerable to
accumulation of genome instability.
Cellular defenses that have evolved to protect the host from
invading pathogens could also inadvertently be contributors to
genomic instability and carcinogenesis. The AID/APOBEC cyti-
dine deaminases play important roles in the immune system,
acting in both innate and adaptive pathways (reviewed by Pavri
and Nussenzweig, 2011; Refsland and Harris, 2013). Activation-
induced cytidine deaminase (AID), a keymediator of the adaptive
humoral immune response, functions to diversify antigen recep-
tor genes through processes of somatic hypermutation (SHM)
and class-switch recombination (CSR). AID may also play a
role in innate immune defense by its activity on viral genomes
that limits their fitness (Refsland and Harris, 2013) and via upre-
gulation of ligands for activating natural killer cell receptors that
marks infected cells for elimination (Bekerman et al., 2013). The
human apolipoprotein B mRNA editing enzyme, catalytic poly-
peptide-like 3 (APOBEC3) proteins comprise seven host restric-
tion factors (APOBEC3A–APOBEC3H) that constitute an innate
barrier to retroviruses, endogenous retroelements, and DNA
viruses. These AID/APOBEC enzymes share the ability to cata-
lyze deamination of cytidine to uracil residues, which can be
processed by cellular DNA glycosylases to produce abasic sites.
If not repaired by the high-fidelity repair systems, the resulting
U:G mismatches will be replicated into C-to-T transitions. Pro-
cessing by BER produces nicks, and if sites are closely located
then they can result in DSBs. The antiviral and immune functions
of AID/APOBEC proteins therefore rely on their ability to
generate mutations, but these come at a high cost if not exqui-
sitely regulated.
It has recently emerged that aberrant activity of AID/APOBEC
proteins can generate somatic mutations and breaks in cellular
genomes, thus turning them into powerful DNA mutators (Burns
et al., 2013; Landry et al., 2011; Okazaki et al., 2007; Robbiani
and Nussenzweig, 2013; Suspe`ne et al., 2011). Constitutive
and ubiquitous AID expression in a transgenic mouse model
led to accumulation of mutations in nonimmunoglobulin (non-
Ig) genes and produced T cell lymphomas and epithelial tumors
(Okazaki et al., 2003). The murine genome possesses only one
APOBEC3 gene, and the impact of human APOBEC3 proteins
expressed in transgenic mice has not yet been reported.
Although expression and activity of AID and APOBEC enzymes
are strongly regulated, pathogens or inflammatory responses
could disrupt these control mechanisms and inadvertently pro-
mote genome instability (Shimizu et al., 2012). Expression of290 Cell Host & Microbe 15, March 12, 2014 ª2014 Elsevier Inc.AID and APOBEC3 proteins can be activated by cytokine
signaling resulting from chronic inflammation and microbial
infections (Petersen-Mahrt et al., 2009; Shimizu et al., 2012).
The activation of NF-kB can produce aberrant AID protein
expression in H. pylori gastric cancer tissues (Matsumoto
et al., 2007) and by HCV in hepatocytes (Endo et al., 2007). Viral
oncoproteins may also lead more directly to increases in AID
activity that could contribute to genomic instability, such as the
latent membrane protein of EBV, which upregulates AID expres-
sion in B cells (Kim et al., 2013). In contrast to these studies that
implicate AID/APOBECs as potential contributors to pathogen-
induced carcinogenesis, there is also evidence to suggest that
DNA damage induced by these enzymes in response to virus
infection could also enhance recognition of infected cells (Nor-
man et al., 2011) and potentially limit transformation (Bekerman
et al., 2013). Upregulation of AID by infection of human B cells
with the oncogenic KSHVmay act on viral genomes to limit reac-
tivation and spread, while also acting on host genomes to induce
DNA damage may result in upregulation of ligands that stimulate
immune cells to remove infected cells (Bekerman et al., 2013).
Therefore, pathogens may upset the delicate balance of AID/
APOBECs between efficient immune function and aberrant
activity on the host genome. It has been speculated that
observed epidemiological association between malaria and
EBV could involve parasite induction of AID by malarial antigens
and that parasite-induced B cell proliferation in children could
increase the EBV-infected compartment or reactivate latent
EBV via increased AID activity (Bouvard et al., 2012). There is
also some evidence that repair pathways involving BER are
downregulated in conditions where bacterial infection is asso-
ciated with cancer (Touati, 2010). Activation of AID/APOBEC
mutator activity as a result of microbial infectionsmay be difficult
to ascribe to infection once pathogens are cleared, making
determination of causality challenging.
Concluding Remarks
The link between infection and cancer is now uncontested, and
yet the molecular mechanisms by which DNA damage contrib-
utes to pathogen-induced genomic instability and tumorigenesis
by infectious agents remain unclear. It is likely that a combination
of genetic and epigenetic aberrations induced by infections
combine to generate molecular events underlying pathogen-
induced tumorigenesis. Viruses directly assault cells with deliv-
ery of foreign genetic material, and every DNA tumor virus so
far examined has intersected with the cellular DNA damage
apparatus. By contrast, relatively little is known about the role
of these pathways in bacterial and parasite infections. Neverthe-
less, it is clear that microbial pathogens can induce genetic
change by increasing DNA damage and decreasing DNA repair
activity that transiently produces a mutator phenotype, while
simultaneously blocking checkpoints and apoptosis. We predict
that future investigation of microbial (both prokaryote and
eukaryote)-host interactions will provide further insight into
genome-to-genome crosstalk in disease. DNA damage path-
ways respond to pathogen infections, but in most cases it is still
unclear what structures are sensed by the cellular machinery.
Dissecting the intersection of microbial pathogens with host
DDR machinery will reveal how cellular sensors recognize
distinct DNA damage. Emerging proteomic techniques will
Cell Host & Microbe
Reviewprovide a clearer view of cellular responses to pathogen infection
and their intersection with DDR signaling pathways. Further-
more, understanding microbial infections associated with
human cancers opens up opportunities for therapeutic interven-
tion and prevention.
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